Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health, discusses findings from the TROPION-Breast01 study on ...

HER2, a HER2-targeted immunotherapy, with plans for FDA submission following promising Phase 2b data in osteosarcoma.

A research team has developed a multi-medium approach (MMA) to identify reproducible volatile organic compounds (VOCs) in ...

Women whose breast cancers need estrogen to grow are often treated for five or more years with medications to lower estrogen production or block its effects. Broadly known as endocrine therapy, the ...

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects. In mouse tests, the new therapy completely eradicated ...

HER2-positive (HER2+) breast cancer treatments come with a range of unpleasant side effects. However, there are strategies ...

Chemotherapy for breast cancer may be more effective during specific stages of the menstrual cycle, according to data from ...

We read with interest the article by Marie Lund and colleagues published in The Lancet Oncology investigating the association ...

It usually develops beneath the skin. While an armpit lump can be a symptom of breast cancer, it is not usually the first sign of breast cancer. Instead, the most common symptom of breast cancer is a ...